Lineage Cell Therapeutics (LCTX.TA) Q1 2025 Earnings

10MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-17.04
-13.79
-10.53
-7.28

Details

Expected EPS
-10.91832
Actual EPS
-7.278880000000001
Surprise EPS
3.64
Surprise Percent
+33.33%

Description

Lineage Cell Therapeutics (LCTX.TA) has reported earnings of -7.278880000000001 per share for Q1 2025.

0 Comments

Share your thoughts